| Detected | Trial | Change |
|---|---|---|
| 2026-06-02 | NCT07405151 A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer… |
Trial sites expanded: 7 -> 15 locations |
| 2026-05-27 | NCT06843447 A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) |
Trial sites expanded: 17 -> 20 locations |
| 2026-05-23 | NCT06966700 A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… |
Trial sites expanded: 287 -> 291 locations |
| 2026-05-16 | NCT06312137 A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab… |
Trial sites expanded: 260 -> 263 locations |
| 2026-05-16 | NCT06966700 A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… |
Trial sites expanded: 283 -> 287 locations |
| 2026-05-16 | NCT06717347 A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus… |
Trial sites expanded: 253 -> 256 locations |
| 2026-05-14 | NCT06843447 A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) |
Enrollment increased: 280 -> 460 participants |
| 2026-05-14 | NCT06843447 A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) |
Trial arms changed: 7 -> 10 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06312137 | A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab… | Non Small Cell Lung Cancer | Recruiting |
| NCT06841354 | A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… | Triple Negative Breast Neoplasms | Recruiting |
| NCT06925737 | A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate… | Prostate Cancer | Recruiting |
| NCT06717347 | A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus… | Diffuse Large B-Cell Lymphoma | Recruiting |
| NCT06966700 | A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… | Breast Neoplasms | Recruiting |
| NCT05776927 | A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate /… | Asthma | Not Yet Recruiting |
| Phase 2 | |||
| NCT06780085 | A Study of Investigational Agents in Participants With Previously Treated Stage IV… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT06780098 | Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated… | Lung Neoplasm | Recruiting |
| NCT06890884 | A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide… | Lymphoma, Large B-Cell, Diffuse | Recruiting |
| Phase 1/2 | |||
| NCT06428409 | A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal… | Colorectal Cancer | Recruiting |
| NCT06780111 | Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT07232602 | KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab… | Bladder Cancer | Recruiting |
| NCT06637423 | A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer… | Non-Muscle Invasive Bladder Cancer | Recruiting |
| NCT06863272 | A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy… | Castration-Resistant Prostatic Cancer | Recruiting |
| NCT07405151 | A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer… | Oesophageal Squamous Cell Carcinoma | Recruiting |
| NCT06843447 | A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) | Ovarian Cancer Recurrent | Recruiting |